1 Most
die within 1 h of transverse aortic constriction, probab
2 donation after cardiac death donors who will
die within 1 or 2 hrs after life-sustaining treatment ha
3 Most patients
die within 1 to 2 years of diagnosis.
4 The latter animals
die within 1 week of birth in the absence of endogenous
5 bled before angiography were more likely to
die within 1 year than patients who did not bleed (8.5%
6 ctions, organ dysfunction, and at least half
die within 1 year.
7 onventional chemotherapy, patients typically
die within 1 year.
8 No patient
died within 1 h of the echocardiographic study.
9 mutants exhibited cardiovascular defects and
died within 1 month.
10 Of these, 75 (5.3%)
died within 1 y during 1318 child-years of observation.
11 igher all-cause mortality among patients who
died within 1 year after biomarker measurement (hazard r
12 patients in a tertiary referral hospital who
died within 1 year after surgery and classified as surge
13 ly 1/3 of Tet2(-/-) and 8% of Tet2(+/-) mice
died within 1 year of age because of the development of
14 lated from a 2-month-old Zambian infant, who
died within 1 year of birth.
15 of women with severe obstetric complications
died within 1 year, compared with 18 of those born by un
16 37 women with severe obstetric complications
died within 1 year, compared with none of the women with
17 ansplants with 1-year follow-up, 576 (10.1%)
died within 1 year.
18 g some subjects who had required amputation)
died within 1 year.
19 plete for 15 361 (99.7%), of whom 1758 (11%)
died within 1 year.
20 d mice transplanted with Dnmt3a-deleted HSCs
died within 1 year.
21 were significantly lower in 114 patients who
died within 1 yr of dialysis initiation than in 109 surv
22 mately 1 of 3 patients hospitalized with CAP
dying within 1 year.
23 ssociated with a 40% increase in the risk of
dying within 1 year.
24 pared with the other E. coli strains but all
died within 10 min on copper surfaces using a 'dry' inoc
25 injury, one in 137 girls and one in 64 boys
died within 10 y, and 54.2% of girls and 40.5% of boys h
26 Thirty patients (16%)
died within 100 days of transplantation; only low serum
27 animals from ischemia/SCS control group all
died within 12 hr postoperatively (n=6).
28 oncomitant pulmonary tuberculosis, and 14.7%
died within 12 months of EPTB diagnosis.
29 Sixty-four case patients who
died within 12 months of treatment-mediated viral suppre
30 Europe, and 255 in Latin America), 264 (19%)
died within 12 months.
31 ved to hospital discharge of which 76 (8.2%)
died within 12 months.
32 The incidence of AL was 6.4%, 744 patients
died within 120 days.
33 is, 76% of them died within 60 mins, and 83%
died within 120 mins after withdrawal of life-sustaining
34 rvival time was 8 years; however, 5 patients
died within 13 months of initiation of treatment.
35 x 10(4) cell/g, 60% of control C57BL/6 mice
died within 14 d compared with 100% mortality of alpha(X
36 A total of 18 (22%) patients
died within 14 days, including 12 (32%) in the CP-CRE gr
37 tibiotic treatment administered, the odds of
dying within 14 days were more than 4 times greater for
38 mutant became necrotic within 7 d and plants
died within 15 d.
39 Four infants
died within 15 days of follow-up in each group.
40 All of the SCIDbgMN mice
died within 16 days of C. parvum infection, while 100% o
41 Abeta(0).beta2m(0) mice infected with TMEV
died within 18 days of infection.
42 fidence interval 1.09-1.72, p</=.01) and for
dying within 180 days was 0.57 (confidence interval 0.44
43 he number of medically suitable patients who
die within 2 hours of planned withdrawal of life-sustain
44 were recovered because the patients did not
die within 2 hours.
45 iF2KO mice lose weight and
die within 2 weeks after the first tamoxifen dose.
46 ially dismal prognosis; >70% of GBM patients
die within 2 years of diagnosis.
47 8 mice that received shHDAC3-infected grafts
died within 2 days after the operation.
48 A higher proportion of patients
died within 2 days of transplantation in LIST group (11%
49 periments showed that 73% of E. coli O157:H7
died within 2 h with a disinfection rate constant of k =
50 n = 1876) who died (n = 446; 24%), 272 (61%)
died within 2 years after listing.
51 Among patients who
died within 2 years of ESRD onset (n = 21,190), those li
52 D/G12D mice treated with MEK inhibitor alone
died within 20 weeks, and the remaining animals continue
53 lly normal at birth but declined rapidly and
died within 21 days.
54 at 80% of the newborn Fgf10 hypomorphic mice
die within 24 h of birth due to respiratory failure.
55 itecture of the neocortex and cerebellum and
die within 24 h of birth.
56 Approximately 0.4% of hospitalized patients
die within 24 h of echocardiography.
57 ice display anuria and kidney hemorrhage and
die within 24 hours after birth.
58 a severely disrupted respiratory rhythm and
die within 24 hours of birth.
59 us and S. pneumoniae, whereas untreated mice
die within 24-33 h.
60 at underwent unenhanced echocardiography, 46
died within 24 h (0.37%).
61 iving Definity during the echocardiogram, 26
died within 24 h (0.42%).
62 ndrocytes treated with AMPA or staurosporine
died within 24 h after treatment.
63 Of the 18,671 patient events, 72 patients
died within 24 h.
64 ate address, or inadequate CT imaging or who
died within 24 hours of admission were excluded.
65 %) were severely injured (ISS > 15), and 80%
died within 24 hours of admission.
66 ients (5%) and 85 of 447 nonrecipients (19%)
died within 24 hours of MEDEVAC rescue (between-group di
67 d that both models developed arrhythmias and
died within 24 hours, while wild-type mice were free of
68 % were in shock; 28% were transfused; and 6%
died within 24 hours.
69 patients who unsuccessfully donated (67.5%)
died within 24 hours.
70 ved ischemic livers without preservation all
died within 24 hr after transplantation (n=6).
71 Twenty-three (7.4%)
died within 24 months of surgery.
72 resent a dramatic phenotype with 60% of pups
dying within 24 h of birth and the surviving animals exh
73 vivors with node-positive disease from those
dying within 24 months.
74 GATA4 and GATA6 in the intestinal epithelium
died within 24h of birth.
75 Among them, 26 (37%)
died within 28 days after ICU admission and were classif
76 patients from all three cohorts, of whom 359
died within 28 days of admission to the intensive-care u
77 copies/microl plasma) had increased odds of
dying within 28 d of ICU admission in both the BWH RoCI
78 -knock-out (KO) mice are born alive but most
die within 3 d after birth showing no overt defects in a
79 8(-/-)) mice that lack core fucose structure
die within 3 days after birth, but the remainder survive
80 s with systemic light-chain amyloidosis (AL)
die within 3 years from diagnosis.
81 The latter 2 subjects
died within 3 and 11 days of enrollment whereas the 36-y
82 PEB2 knock-out (KO) mice and found that most
died within 3 d after birth.
83 n of 37 TLR2(-/-) mice showed bacteremia and
died within 3 days after the challenge, compared to only
84 Patients who
died within 3 days of admission were excluded from analy
85 All control animals
died within 3 days.
86 ied to the data from 2006, when 477 patients
died within 3 months after registration on the waiting l
87 evertheless, 10 of 42 split liver recipients
died within 3 months after transplantation.
88 Two patients (< 1%)
died within 3 months of starting therapy.
89 erapy, 68% of meningitis patients (23 of 34)
died within 3 months.
90 s of rapidly dividing cells, and mutant mice
died within 3 to 10 days after induction with dramatic a
91 susceptible to SFTSV infection, and all mice
died within 3 to 4 days after subcutaneous inoculation o
92 mber ( approximately 75%) of TA motoneurones
died within 3 weeks after neonatal axotomy.
93 112 patients in the efficacy population, 875
died within 3 years after the start of the study treatme
94 One female, who
died within 3 years of acquiring SIVcpz, had histopathol
95 ng persons with HCV who died, more than half
died within 3 years of an HCV report to DOHMH.
96 Nearly one-third of Medicare ICD recipients
died within 3 years, reflecting a population with more a
97 Patients
dying within 3 months had significantly higher hepcidin
98 IL-2-KO) mice develop systemic autoimmunity,
dying within 3 to 5 wk from complications of autoimmune
99 pitalized, visit an emergency department, or
die within 30 days after discharge from an acute hospita
100 nostic value to discriminate those likely to
die within 30 days for the model with peak TnT measureme
101 nostic value to discriminate those likely to
die within 30 days for the model with peak TnT measureme
102 IS volumes <126 annually are more likely to
die within 30 days than patients admitted to hospitals t
103 surgery each year, more than 1 million will
die within 30 days.
104 surgery each year, more than 1 million will
die within 30 days.
105 re readmitted or died within 30 days; 72,472
died within 30 days (4.7%; 99% CI, 4.7%-4.8%), and 321,7
106 nts admitted as weekend emergency admissions
died within 30 days (p<0.0001).
107 Twenty-seven (32%) patients
died within 30 days after a MBE.
108 Only 0.7% of patients
died within 30 days after admission (50 deaths), and mos
109 The SM2 homozygous knockout (SM2(-/-)) mice
died within 30 days after birth, showing pathologies inc
110 Patients who
died within 30 days after TAVI were excluded.
111 A total of 19 patients (3.4%)
died within 30 days after the MitraClip procedure.
112 placement, and 15.8% needed ventilation; 23%
died within 30 days and 21.6% developed second infection
113 14 (13%) of 105 patients
died within 30 days and 27 (26%) died within 60 days.
114 Two patients in the EPP group
died within 30 days and a further patient died without l
115 Forty-nine patients (23.6%) who
died within 30 days had higher admission MELD (25 versus
116 All patients who
died within 30 days of a PCI from January 2009 to April
117 One patient
died within 30 days of CHLT.
118 Five patients
died within 30 days of clofarabine administration second
119 in the emergency department, and 840 (7.5%)
died within 30 days of discharge.
120 patients and none of the 29 control patients
died within 30 days of enrollment (P=.58).
121 e negative (p = 0.0023) as well as those who
died within 30 days of hospital admission (p = 0.025).
122 Higher percentages of patients with AKI
died within 30 days of hospitalization (34% vs 7%), were
123 Patients were excluded from analysis if they
died within 30 days of randomization (n=89), did not rec
124 Twelve (14%) patients
died within 30 days of receiving laromustine therapy.
125 Six patients (8%)
died within 30 days of registration.
126 treated with induction therapy and those who
died within 30 days of surgery were excluded from analys
127 Six patients (3.9%)
died within 30 days of surgery, and overall 1-year morta
128 patients (24.53%), and 114 patients (4.27%)
died within 30 days of surgery.
129 Six patients
died within 30 days of surgery.
130 lications (18.3%), and 18924 patients (2.7%)
died within 30 days of surgery.
131 ncluded 14,037 patients, 267 (1.9%) patients
died within 30 days of surgery.
132 nfidence interval 7.5-16.2%); seven children
died within 30 days of their episode of convulsive statu
133 1013 (33.3%) received statins and 151 (5.0%)
died within 30 days of their influenza test.
134 27 patients
died within 30 days of treatment in the cabazitaxel and
135 from 59 patients who presented with ACS and
died within 30 days were included.
136 9 of 73 (26%) patients in the overall cohort
died within 30 days, but there was no significant differ
137 e, 59 years) were included; 39 (6%) patients
died within 30 days.
138 te peripheral blood count recovery), and 18%
died within 30 days.
139 or epinephrine, suffered cardiac arrest, or
died within 30 days.
140 .3%; 99% CI, 23.3%-23.5%) were readmitted or
died within 30 days; 72,472 died within 30 days (4.7%; 9
141 One patient who
died within 30 minutes of admission was excluded.
142 (all P < 0.04), and were at greater odds of
dying within 30 days after colectomy, heart valve repair
143 ent increased the likelihood of an inpatient
dying within 30 days of admission by 7% (odds ratio 1.06
144 At the patient level, the odds of
dying within 30 days of admission if treated at a hospit
145 ctors on the likelihood of surgical patients
dying within 30 days of admission, before and after adju
146 039-1.294) increase in the odds of a patient
dying within 30days of admission respectively.
147 epithelial cells develop immunotoxicity and
die within 32 days, indicating that GI tract inducible C
148 participants with M. tuberculosis bacteremia
died within 36 days of enrollment.
149 adult sensory ganglia, up to 27% of neurons
die within 4 days (d) in culture and this can be prevent
150 e develop a lymphoproliferative disorder and
die within 4 weeks of birth, suggesting a role for CTLA-
151 rvival, whereas all PBS-treated control mice
died within 4 days of infection, all AGP-treated mice sh
152 Among 708 patients, 86 (12%)
died within 4 days, 140 (20%) died between days 4 and 28
153 f age and low body weight (mean, 6 vs. 9 kg)
died within 4 months posttransplant.
154 19 (39%) had resistant disease, and two (4%)
died within 4 weeks of starting treatment.
155 Whereas all GCase-inhibited mice
died within 4-5 weeks, mice deficient in both GCase and
156 ly 40% of Cx30/Cx47 double-deficient animals
died within 42 to 90 d after birth, accompanied by sever
157 Jam-C-deficient mice showed that two-thirds
die within 48 hours after birth.
158 tectable Nissl substance) at 12-24 hours and
die within 48 hours.
159 ith bicuspid aortic valves, and patients who
died within 48 h after AVR were excluded.
160 Two of the TKM-130803 recipients
died within 48 h of admission and were therefore exclude
161 y 14 after admission, excluding patients who
died within 48 h of admission.
162 stage IB non-small-cell lung cancer (NSCLC)
die within 5 years after surgery.
163 All irradiated mice
died within 5 d of infection, whereas no mortality was s
164 posed to the pathogen, and all of these mice
died within 5 days of infection.
165 ockade as monotherapy or combination therapy
died within 5 years of diagnosis.
166 d adenocarcinoma of the esophagus, 323 (53%)
died within 5 years of surgery, and 235 (39%) died of tu
167 36.1% underwent retransplantation and 15.4%
died within 5 years.
168 50.4% underwent retransplantation and 12.1%
died within 5 years; after the second graft failure, 36.
169 Cre(ERT2)/Myocd(F/F) conditional mutant mice
die within 6 mo of Myocd gene deletion, exhibiting profo
170 [CI], 1.5 to 3.6) and 3.7 times as likely to
die within 6 months after therapy (95% CI, 2.3 to 5.9).
171 olled in Medicare who are admitted to an ICU
die within 6 months of admission.
172 nd older admitted to the intensive care unit
die within 6 months of hospital discharge.
173 or chemotherapy whom oncologists expected to
die within 6 months were interviewed before and after a
174 All recipients in WI-SCS group
died within 6 hours after transplantation.
175 the basis of clinical outcome: patients who
died within 6 mo (group 1 [G1], n = 4), survived 6-12 mo
176 Patients who
died within 6 months after surgery were excluded.
177 those with burst suppression, 29 of 49 (59%)
died within 6 months compared with 25 of 76 (33%) who di
178 diac dysfunction and atrial fibrillation and
died within 6 months of age.
179 Fewer patients
died within 6 months of diagnosis in the 2 later periods
180 However, most patients with HF who
died within 6 months of hospital discharge did not recei
181 ath before discharge (93%), 112 patients had
died within 6 months of medical ICU discharge, and only
182 eceived prolonged mechanical ventilation and
died within 6 months of their index procedure spent the
183 not receiving hospice referrals, 1608 (20%)
died within 6 months post discharge (the hospice-eligibl
184 or NY-ESO-1 and 23% for Melan-A in those who
died within 6 months.
185 n of 2.4 years, 415 patients died: 108 (26%)
died within 6 months.
186 admitted to the MICU within 48 hrs and 35.5%
died within 6 months; however, no deaths occurred within
187 kb1 mice exhibited body weight reduction and
died within 6 weeks after tamoxifen induction.
188 No patients
died within 6 weeks of induction.
189 requires identification of patients who will
die within 60 min of withdrawal of life-sustaining treat
190 The probability to
die within 60 mins for each patient in this validation s
191 imination (distinction of those patients who
die within 60 mins from those who do not, expressed by t
192 Half of all ICU patients
die within 60 minutes of withdrawal of cardiorespiratory
193 dmitted with upper gastrointestinal bleeding
died within 60 days of admission, signifying a high burd
194 t patients died on TKI therapy, two patients
died within 60 days of being off TKIs, and 23 patients d
195 Two patients, both immunocompromised adults,
died within 60 days of symptom onset.
196 of interest; 71,583 of these patients (8.2%)
died within 60 days of their index operation.
197 05 patients died within 30 days and 27 (26%)
died within 60 days.
198 59 of 82 patients who
died within 60 min of WLST had DCD-N scores of 3 or more
199 We included 178 patients, 82 (46%) of whom
died within 60 min of WLST.
200 odel discriminated well between patients who
died within 60 mins after withdrawal of life support and
201 th donors, 211 entered analysis, 76% of them
died within 60 mins, and 83% died within 120 mins after
202 Fifty (61%)
died within 60 mins.
203 carcinoma and neuroendocrine tumors, and all
died within 65 weeks.
204 ndred ninety-six patients were readmitted or
died within 7 days of discharge.
205 hospice was 15, and 39% of the beneficiaries
died within 7 days of enrollment.
206 Eight patients
died within 7 days of the index request: five in the GP-
207 n of 35 (51%) patients in the surgical group
died within 7 days of valve surgery.
208 The percentage of patients with AMI who
died within 7 days, 30 days, 90 days, 9 months, and 1 ye
209 The animal
died within 7 minutes of VAE.
210 Approximately 15% of all patients had
died within 7 to 9 years of follow-up.
211 Eln(-)(/)(-) mice
die within 72 hours of birth but are viable throughout f
212 One
died within 72 hours and was not assessable.
213 Two neonates born live in the ETU
died within 8 days.
214 t differ after exclusion of participants who
died within 8 years of baseline.
215 Three
died within 8 years of primary HCV infection, and 1 surv
216 nimals, whereas RC/RC- and RW/RW-mutant mice
died within 9 days after birth.
217 These recipients
died within 9 to 11 days, demonstrating that in hematopo
218 ed to synthesize BZLF1 RNA, with 90% of them
dying within 9 days postinfection.
219 anterior circulation, 60 to 80% of patients
die within 90 days after stroke onset or do not regain f
220 tment, patients with ALD were less likely to
die within 90 days when compared with patients with NASH
221 underwent liver transplantation and 422 who
died within 90 days after registration on the waiting li
222 d CDI within 30 days after the index test or
died within 90 days after the index toxin EIA date.
223 Of 10,159 patients listed for HT, 596 (5.9%)
died within 90 days and 1,054 (10.4%) within 1 year with
224 Of 2034 HT recipients, 6.8%
died within 90 days and 10.8% within 1 year.
225 Only 26% of candidates removed as "too sick"
died within 90 days of delisting; 6335 deaths after deli
226 ncer between 2000 and 2010, 209 patients who
died within 90 days of surgery and 296 patients with a R
227 1743 patients
died within 90 days of surgery during 8 years, with a su
228 rrence, we excluded patients who recurred or
died within 90 days of their multivitamin assessment.
229 statins before blood cultures and 677 (32%)
died within 90 days.
230 available for analysis of whom 3797 (30.4%)
died within 90 days.
231 Forty-five neonates (33.1%) ultimately
died within 90 minutes of withdrawal of life-sustaining
232 culture-positive patients, including 9/9 who
died within 90-days.
233 tive TB blood culture, of these 9/41 (22.0%)
died within 90-days.
234 ienced a significant decrease in the odds of
dying within 90 days of admission compared with patients
235 However, they are small, and 60%
die within a few hours after birth.
236 epidermal permeability barrier function, and
die within a few hours after birth.
237 Mice are born but never feed and
die within a few hours.
238 Animals usually
die within a few months with no evidence of antibody or
239 sive neurodegenerative process, and patients
die within a few years after disease onset.
240 ants have a growth retardation phenotype and
die within a month after birth.
241 patients with M. tuberculosis bacteremia may
die within a month of hospitalization.
242 exhibit detectable proteinuria on day 1 and
die within a week.
243 iratory unit were seven times more likely to
die within a year than those who did (odds ratio, 6.55;
244 Nine patients
died within a 30-day period after discontinuing sorafeni
245 lt mice (cFlip(iDeltaIEC) mice), the animals
died within a few days from severe tissue destruction, e
246 ted patients developed cardiogenic shock and
died within a few days of T-cell infusion, events not pr
247 Nontransplanted hemophilia A mice
died within a few hours, whereas transplanted mice survi
248 in an adenosine kinase-dependent process and
dies within a few hours.
249 en after psychiatric illness and the risk of
dying within a year were accounted for.
250 fraction is high, with one third of patients
dying within a year.
251 Most patients
died within an hour of left ventricular assist device de
252 Homozygous Zfp36l2 knockout (KO) mice
died within approximately 2 weeks of birth, apparently f
253 The activity of the rather dilute enzyme
dies within approximately 60 min.
254 cardiac disease, and hyperoxia-treated mice
die within days from acute pulmonary edema.
255 Upon return to normoxia, Ndufs4 KO mice
die within days.
256 absorption was perturbed, and neonatal mice
died within days of birth.
257 Males were also more likely to
die within each age range assessed (eg, 15-24, 25-29, 30
258 water live for weeks, whereas the same cells
die within hours if transferred into water with 2% gluco
259 psis, and in established cases an infant may
die within hours of diagnosis.
260 early in lung development leads to pups that
die within hours of parturition, exhibiting symptoms sim
261 tive barrier to the external environment and
died within hours of birth.
262 Without oxygen, most vertebrates
die within minutes as they cannot meet cellular energy d
263 urvival is highly variable, as some patients
die within months, while others live for many years.
264 oma patients with metastatic disease usually
die within one year, emphasizing an urgent need to devel
265 s of the RRT event and many patients (46.8%)
died within one day of the consultation.
266 mice homozygous for a null allele of Tmem16a
died within one month of birth and exhibited severe trac
267 d the early post-weaning lethality, but most
died within one year of age.
268 rom the derivation cohort (n = 95 977), 2.7%
died within one year.
269 dly develop worsening weakness and uniformly
die within several days.
270 Four patients
died within six months due to postoperative complication
271 embryonic development, but fail to feed and
die within the first 2 post-natal days.
272 discharged to an ICF are much more likely to
die within the first postoperative year and ICF disposit
273 Patients who
died within the 14 day study period were recorded as hav
274 When combined, only one of nine mice
died within the 30-week study; aortic histology and diam
275 a at their last visit, known APOE4 genotype,
died within the ensuing 24 months, and underwent neuropa
276 ,640 people who started treatment, 58 (1.6%)
died within the first 16 weeks in care, and an additiona
277 developed a runting syndrome after birth and
died within the first 2 weeks.
278 Four patients (2 in each group)
died within the first 30 postoperative days.
279 at 365 days even after removing patients who
died within the first 30 postoperative days.
280 Three subjects (2%)
died within the first 7 days, 107 (79%) exhibited rapid
281 We excluded patients who
died within the first 72 hr after transplantation, were
282 Half of patients (n = 22; 8.6%)
died within the first five years.
283 Of the 71 617 patients, 7878 (11%) had
died within the first month; of these, stroke was the ca
284 While some mutant mice
died within the first week after birth, others survived
285 r surgical procedures were rehospitalized or
died within the first year after discharge.
286 Eighty-one patients
died within the first year after HDM/SCT and were not ev
287 lthough a substantial proportion of patients
died within the first year.
288 Sixty of 346 patients (17%)
died within the first year.
289 0%) with troponin concentrations >0.01 ng/mL
died within the follow-up period, 7 of which had concent
290 bal autopsy, which was done on all those who
died within the study areas.
291 1980s, 18% of those who survived for 5 years
died within the subsequent 25 years.
292 a, potentially salvageable brain tissue that
dies within the first few hours after blood flow cessati
293 conditional knockout mice failed to survive,
dying within the first 24 hours of birth.
294 The risk of
dying within the first three years after a HL diagnosis
295 rriers to access to surgical care of persons
dying within the past year were analyzed.
296 sitivity), and 75 of 96 of those who did not
die within this interval had scores of 0-2 (78% specific
297 Four of the control animals
died within this period (p=0.03).
298 It was highest for upper GI malignancy (95%
died within three years) and varices (52%).
299 Although the majority of these cells
die within two weeks of their birth, they can be rescued
300 tching to a high fat diet, the mice begin to
die within weeks and display signs of severe hypertrophi